Features

Viewpoints

New Trial Attempts to Make Genetic Counseling and Testing More Accessible

By

Agata Boxe

Publish Date August 13, 2019

The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.”

T-Cell Cryopreservation for Use in Future Cancer Treatment: Hot or Hype?

By

Kristin Bundy

Publish Date August 12, 2019

Can healthy immune cells from a patient be frozen and used in the future to make adoptive cell therapies in the event of a cancer diagnosis?

From the Advisory Board

We Can Treat Hodgkin’s Lymphoma Like Melanoma?

By

Isabel Cunningham, MD

Publish Date September 3, 2015

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Slideshows

BAVENCIO (avelumab) for Merkel Cell Carcinoma

IMLYGIC (talimogene laherparepvec) for Melanoma

Features

Previously Hidden FDA Data Reveal a Multitude of Adverse Events Linked to Breast Implants

By

Agata Boxe

Publish Date August 21, 2019

Why were adverse events reported through an alternative reporting channel as opposed to a more transparent means?

Personalized Cancer Vaccine NEO-PV-01 Shows Promise in 3 Types of Advanced Cancer

By

Victoria Forster, PhD

Publish Date August 20, 2019

Early results from a clinical trial of personalized cancer vaccine NEO-PV-01 in 3 types of advanced cancer have shown promise and no significant toxicity issues.

Looking at Survival Differently in Patients With Metastatic Kidney Cancer

By

Christina Bennett, MS

Publish Date August 19, 2019

Conditional survival may more accurately assess prognosis than traditional survival for patients with metastatic kidney cancer, but the metric is not without its caveats.